FDA GDUFA Testimony Presentation Slides

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-02-2016
Volume 40
Issue 3

Slides from the FDA GDUFA presentation before the Senate Health, Education, Labor and Pensions Committee in January 2016.

Slides from the FDA GDUFA presentation before the Senate Health, Education, Labor and Pensions Committee in January 2016.

External Link - GDUFATestimony_presentationslides.pdf

Articles in this issue
Gaining Insight from Process Control Data
Gaining Insight from Process Control Data
PT0316_Troubleshooting_495forweb.gif
Designing a Biomanufacturing Facility Incorporating Single-Use Technologies
Generic-Drug Production and Oversight Challenge FDA and Manufacturers
Phase-Appropriate GMP
How Important is Data Integrity to Regulatory Bodies?
How Important is Data Integrity to Regulatory Bodies?
FDA GDUFA Testimony Presentation Slides
Keynote Series Addresses Crucial Industry Issues
Polymorph Screening for Identification of Relevant Crystalline Forms
Polymorph Screening for Identification of Relevant Crystalline Forms
Building Consensus for E&L Testing Standards
Building Consensus for E&L Testing Standards
Tecan_225.jpg
Multimode Microplate Reader Improves Sensitivity
Thermo_225.jpg
High-Pressure Ion Chromatography System
Zeiss_225.jpg
Confocal Microscope for Surface Analysis
Pharma Outsourcing Market Expands
Redefining Pharma Agility
Redefining Pharma Agility
Tackling Regulatory Challenges of EU’s Variations Framework
Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Related Content
Pharmaceutical research and development in laboratory, with focus on medicine preparation, powder substances, and glass vials for drug formulation and testing | Image Credit: © felix_brönnimann - stock.adobe.com

Dosage Form Compounding in the Workplace Environment

Paul L. Pluta;Alan M. Mancini;Nishant B. Thakar;Varanya Chaiyaperm
July 8th 2025
Article

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

low angle view of marble dome of United States Capitol building in Washington DC with blue sky and visible architecture features | Image Credit: © Philip - stock.adobe.com

9 Implications of Trump’s Tax-Cut and Spending Bill for the Bio/Pharmaceutical Industry

Christopher Cole
July 7th 2025
Article

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting strategy across the bio/pharmaceutical industry.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

medicine and vision concept - woman closeup and eye diagram, future technologies | Image Credit: ©Julia - stock.adobe.com

Advanced Solutions for Sustained Delivery of Ocular Therapies

Cynthia A. Challener
July 4th 2025
Article

Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.

Old rusty shovel in the ground on the building | Image Credit: © photolink - stock.adobe.com

Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan

Patrick Lavery
July 2nd 2025
Article

The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.